Biocryst Pharmaceuticals (BCRX) Non-Current Debt (2011 - 2026)
Biocryst Pharmaceuticals' Non-Current Debt was $395.4 million in Q2 2026, up 62.9% from $242.79 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Non-Current Debt (2011 - 2026) Analysis & Trends
At the end of FY2024, Non-Current Debt at Biocryst Pharmaceuticals came in at $314.87 million, up 3.8% from FY2023.
- Non-Current Debt has now increased for seven consecutive years, with a five-year compound annual growth rate of 50.1% (FY2019 to FY2024).
- In earlier years, Non-Current Debt was $303.23 million in FY2023 (+30.9%), $231.62 million in FY2022 (+70.2%), $136.08 million in FY2021 (+13.7%) and $119.74 million in FY2020 (+190.0%).
- The Q2 2026 figure marks the highest quarterly Non-Current Debt in data going back to Q2 2011.
- Compared with a year earlier, Non-Current Debt was higher in five of the last seven quarters, with growth averaging 5.6%.
- The best year-over-year quarter for Non-Current Debt over five years was Q3 2021 (growth of 391.0%); the worst was Q3 2025 (a decline of 38.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 395.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 395.40 Mn |
| Mar 31, 2026 | 395.20 Mn |
| Sep 30, 2025 | 194.37 Mn |
| Jun 30, 2025 | 242.79 Mn |
| Mar 31, 2025 | 315.41 Mn |
| Dec 31, 2024 | 314.87 Mn |
| Sep 30, 2024 | 314.33 Mn |
| Jun 30, 2024 | 313.82 Mn |
| Mar 31, 2024 | 308.48 Mn |
| Dec 31, 2023 | 303.23 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 293.18 Mn |
| Mar 31, 2023 | 232.52 Mn |
| Dec 31, 2022 | 231.62 Mn |
| Sep 30, 2022 | 223.87 Mn |
| Jun 30, 2022 | 144.52 Mn |
| Mar 31, 2022 | 140.24 Mn |
| Dec 31, 2021 | 136.08 Mn |
| Sep 30, 2021 | 132.05 Mn |
| Jun 30, 2021 | 126.80 Mn |
API Access
Biocryst Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();